Dr. Linda Chu welcomes Dr. Robert McDonald (Mayo Clinic) and Dr. Paul Evans (GE HealthCare) for a discussion on the evolution of MR contrast agents, exploring how gadolinium has changed MRI diagnostics and what decades of clinical experience have taught the radiology community. The conversation also looks ahead to emerging contrast technologies, including iron and manganese based agents and other innovations that could shape the future of MR imaging, safety, and sustainability. Sponsored by GE HealthCare

<div> Dr. Linda Chu welcomes Dr. Robert McDonald (Mayo Clinic) and Dr. Paul Evans (GE HealthCare) for a discussion on the evolution of MR contrast agents, exploring how gadolinium has changed MRI diagnostics and what decades of clinical experience have taught the radiology community. The conversation also looks ahead to emerging contrast technologies, including iron and manganese based agents and other innovations that could shape the future of MR imaging, safety, and sustainability. Sponsored by GE HealthCare   </div>

Evolution of MR Contrast Agents- Sponsored by GE HealthCare

Description